Novartis wins USFDA breakthrough tag for Capmatinib to treat lung cancer Medical Dialogues Bureau8 Sept 2019 9:25 AM ISTNovartis is aiming to win approval for oral capmatinib as a first-line treatment for patients with metastatic MET exon14 skipping-mutated non-small...